One-day DCF regimen in patients with metastatic gastric cancer

Dirican A., Kucukzeybek Y., Tarhan M. O. , Somali I., Erten C., DEMİR L. , ...More

TUMORI J, vol.99, no.2, pp.145-148, 2013 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 99 Issue: 2
  • Publication Date: 2013
  • Doi Number: 10.1700/1283.14183
  • Title of Journal : TUMORI J
  • Page Numbers: pp.145-148


Background. Cytotoxic chemotherapy is the basic treatment for metastatic gastric cancer. The "docetaxel, cisplatin, 5-day infusion of 5-FU (DCF5)" regimen is regarded as an effective therapy. However, the poor toxicity profile of this regimen and administration by 5-day infusion are major drawbacks of this method.